Home > ERS Monographs
Lung Cancer

Lung Cancer

Product Code: ERM68-MEM-26041
  • The maximum order value is currently 150. For larger requirements, please place several orders or contact books@ersnet.org

    Edited by Anne-Marie C. Dingemans, Martin Reck and Virginie Westeel
    Lung cancer is the most common cause of death from cancer worldwide it is estimated to cause nearly one in five cancer deaths. Most lung cancer patients are diagnosed late and for many of them, there are currently no curative therapy options available, meaning long-term survival is still low. Nevertheless, enormous progress has been made in the field during the last decade. This Monograph provides a comprehensive overview of the current knowledge of and advances in lung cancer, covering areas such as: screening; tobacco control; COPD; diagnosis; therapy; and treatment of early stage lung cancer from both a surgeons and radiation oncologists perspective. Very recent achievements in innovative fields, such as targeted therapies and immunotherapies, are also discussed.

    If you would like to buy this book as eBook only and not receive a print copy, visit books.ersjournals.com

    Contents list
    1. Epidemiology: development and perspectives
    2. Screening
    3. Tobacco control 
    4. The association with COPD
    5. Idiopathic pulmonary fibrosis
    6. Histological diagnosis: recent developments
    7. The current of future roles of genomics
    8. Molecular pathology
    9. Adequate tissue for adequate diagnosis: what do we really need?
    10. Management of early stage lung cancer: a surgeon's perspective 
    11. Management of early stage lung cancer: a radiation oncologist's perspective
    12. Mediastinal staging
    13. Approaches in patients with locally advanced NSCLC: a surgeon's perspective
    14. Approaches in patients with locally advanced NSCLC: a radiation oncologist's perspective
    15. Chemotherapy 
    16. Systemic treatment of elderly patients 
    17. Achievements in targeted therapies
    18. Can we expect progress from targeted therapy of SCLC?
    19. Immunotherapy
    20. Perspective of a pulmonologist: what might we expect and what do we need to know?

    ISBN: 978-1-84984-061-3

  • Delivery costs are calculated at the point of checkout.
    Orders are batched weekly and delivered from the UK.
    Delivery times (estimated) are as follows:
    Europe: 7-15 business days from date of despatch. 
    Rest of the World: 20-25 business days from date of despatch.
    Customers will be notified by email upon despatch.

Customer Reviews
Write an online review and share your thoughts with other shoppers!